Skip to main content

Table 2 Psoriasis scores, physician’s score, patient-reported outcomes among participants with or without musculoskeletal pain

From: The musculoskeletal impairment negatively impacts the quality of life of children and adolescents with psoriasis

ScoresGroupsP value*
No pain (n = 27)
median (min-max)
MSKa Pain (n = 16)
median (min-max)
PASIb2 (0–30.2)5.4 (0.8–16.5)<  0.01
NAPSIc9 (3–36)18 (8–36)<  0.001
PhysMSK VASd0 (0–0)1.5 (0–5)<  0.001
Patient Global VAS0.5 (0–5.1)3 (0–9)0.04
Pain VAS0 (0–5)2 (0–9)<  0.01
CHAQe0 (0–0.5)0.1 (0–1.4)<  0.001
CDLQIf1 (0–13)6 (1–21)<  0.001
PedsQLg 4.0 - Total Score85.1 (63.6–100.0)69.7 (10.6–94.2)<  0.001
PedsQL 4.0 - Physical Health93.7 (59.4–100)71.8 (12.5–96.9)<  0.001
PedsQL 4.0 - Emotional Functioning77.5 (30–100)50 (5–90)<  0.01
PedsQL 4.0 - Social Functioning92.5 (70–100)85 (20–100)0.04
PedsQL 4.0 – School Functioning80 (50–100)65 (5–90)<  0.01
PedsQL 4.0 - Psychosocial Health81.7 (0–100.0)64.2 (0–93.3)<  0.01
PedsQL-MFSh - Total Fatigue86.8 (51.4–100)60.4 (6.9–8.7)<  0.001
PedsQL-MFS – General Fatigue91.6 (58.3–100)64.6 (12.5–100)<  0.01
PedsQL-MFS – Sleep/Rest Fatigue87.5 (50–100)64.6 (4.2–83.3)<  0.001
PedsQL-MFS – Cognitive Fatigue81.2 (8.3–100)50.0 (4.2–91.6)0.04
  1. aMSK musculoskeletal, bPASI Psoriasis Area and Severity Index, cNAPSI Nail Psoriasis Severity Index, dPhysMSK VAS Physician musculoskeletal Visual Analog Scale, eCHAQ Childhood Health Assessment Questionnaire, fCDLQI Children Dermatology Life Quality Index, gPedsQL Pediatric Quality of Life Inventory, hPedsQL-MFS Pediatric Quality of Life Inventory- Multidimensional Fatigue Scale
  2. *Mann-Whitney U test